These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 17473695
1. Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma. Baek SK, Woo JS, Kwon SY, Lee SH, Chae YS, Jung KY. Laryngoscope; 2007 May; 117(5):911-6. PubMed ID: 17473695 [Abstract] [Full Text] [Related]
2. [Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof]. He F, Li H, Li WS, Dong XH. Zhonghua Yi Xue Za Zhi; 2009 Feb 17; 89(6):393-6. PubMed ID: 19567117 [Abstract] [Full Text] [Related]
3. Differential expression of mucins 1-6 in papillary thyroid carcinoma: evidence for transformation-dependent post-translational modifications of MUC1 in situ. Magro G, Schiappacassi M, Perissinotto D, Corsaro A, Borghese C, Belfiore A, Colombatti A, Grasso S, Botti C, Bombardieri E, Perris R. J Pathol; 2003 Jul 17; 200(3):357-69. PubMed ID: 12845632 [Abstract] [Full Text] [Related]
4. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas. Singh AP, Chauhan SC, Bafna S, Johansson SL, Smith LM, Moniaux N, Lin MF, Batra SK. Prostate; 2006 Mar 01; 66(4):421-9. PubMed ID: 16302265 [Abstract] [Full Text] [Related]
5. Clinical impact of MUC1 and MUC4 expression in Barrett-associated oesophageal adenocarcinoma. Piessen G, Wacrenier A, Briez N, Triboulet JP, Van Seuningen I, Mariette C. J Clin Pathol; 2009 Dec 01; 62(12):1144-6. PubMed ID: 19946103 [Abstract] [Full Text] [Related]
6. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, Hollingsworth MA, Büchler MW, Aubert JP, Batra SK. Clin Cancer Res; 2001 Dec 01; 7(12):4033-40. PubMed ID: 11751498 [Abstract] [Full Text] [Related]
7. Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinoma. Nam KH, Noh TW, Chung SH, Lee SH, Lee MK, Hong SW, Chung WY, Lee EJ, Park CS. Thyroid; 2011 Jul 01; 21(7):745-50. PubMed ID: 21615302 [Abstract] [Full Text] [Related]
8. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Shibahara H, Tamada S, Higashi M, Goto M, Batra SK, Hollingsworth MA, Imai K, Yonezawa S. Hepatology; 2004 Jan 01; 39(1):220-9. PubMed ID: 14752841 [Abstract] [Full Text] [Related]
9. The expression and role of serum response factor in papillary carcinoma of the thyroid. Kim HJ, Kim KR, Park HS, Jang KY, Chung MJ, Shong M, Moon WS. Int J Oncol; 2009 Jul 01; 35(1):49-55. PubMed ID: 19513551 [Abstract] [Full Text] [Related]
10. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Tamada S, Shibahara H, Higashi M, Goto M, Batra SK, Imai K, Yonezawa S. Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4257-64. PubMed ID: 16857800 [Abstract] [Full Text] [Related]
11. The expression of MUC4 and MUC5AC is related to the biologic malignancy of intraductal papillary mucinous neoplasms of the pancreas. Kanno A, Satoh K, Kimura K, Hirota M, Umino J, Masamune A, Satoh A, Asakura T, Egawa S, Sunamura M, Endoh M, Shimosegawa T. Pancreas; 2006 Nov 15; 33(4):391-6. PubMed ID: 17079945 [Abstract] [Full Text] [Related]
12. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas. Kamoshida S, Ogane N, Yasuda M, Muramatsu T, Bessho T, Kajiwara H, Osamura RY. Mod Pathol; 2000 Jul 15; 13(7):736-41. PubMed ID: 10912932 [Abstract] [Full Text] [Related]
13. Apolipoprotein e expression in anaplastic thyroid carcinoma. Ito Y, Takano T, Miyauchi A. Oncology; 2006 Jul 15; 71(5-6):388-93. PubMed ID: 17690558 [Abstract] [Full Text] [Related]
14. MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid. Bièche I, Ruffet E, Zweibaum A, Vildé F, Lidereau R, Franc B. Thyroid; 1997 Oct 15; 7(5):725-31. PubMed ID: 9349575 [Abstract] [Full Text] [Related]
15. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation. Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M. Hum Pathol; 2008 Nov 15; 39(11):1656-63. PubMed ID: 18657294 [Abstract] [Full Text] [Related]
16. Cribriform-morular variant of papillary carcinoma: the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma. A case report with clinical and molecular genetic correlation. Ng SB, Sittampalam K, Goh YH, Eu KW. Pathology; 2003 Feb 15; 35(1):42-6. PubMed ID: 12701683 [Abstract] [Full Text] [Related]
17. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions. Brzeziańska E, Cyniak-Magierska A, Sporny S, Pastuszak-Lewandoska D, Lewiński A. Neuro Endocrinol Lett; 2007 Aug 15; 28(4):341-50. PubMed ID: 17693985 [Abstract] [Full Text] [Related]
18. Expression and significance of c-met protein in papillary thyroid carcinoma. Inaba M, Sato H, Abe Y, Umemura S, Ito K, Sakai H. Tokai J Exp Clin Med; 2002 Aug 15; 27(2):43-9. PubMed ID: 12472169 [Abstract] [Full Text] [Related]
19. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence. Ho SB, Ewing SL, Montgomery CK, Kim YS. Oncol Res; 1996 Aug 15; 8(2):53-61. PubMed ID: 8859775 [Abstract] [Full Text] [Related]
20. MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio. Bax DA, Haringsma J, Einerhand AW, van Dekken H, Blok P, Siersema PD, Kuipers EJ, Kusters JG. J Clin Pathol; 2004 Dec 15; 57(12):1267-72. PubMed ID: 15563666 [Abstract] [Full Text] [Related] Page: [Next] [New Search]